Back
Cartesian Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
RNAC
Cartesian Therapeutics, Inc.
Last Price:
$7.43
Seasonality Move:
-8.81%
7 Day Trial
ALL ACCESS PASS
$
7
Cartesian Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Cartesian Therapeutics, Inc. has on average historically fallen by 17.2% based on the past 9 years of stock performance.
-
Cartesian Therapeutics, Inc. has fallen lower in 8 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 88.89%
-
Is Cartesian Therapeutics, Inc. Stock Undervalued?The current Cartesian Therapeutics, Inc. [RNAC] share price is $7.60. The Score for RNAC is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
RNAC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Cartesian Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Cartesian Therapeutics, Inc. has on average historically fallen by 17.2% based on the past 9 years of stock performance.
Cartesian Therapeutics, Inc. Stock Rating
Sell
28
Cartesian Therapeutics, Inc. (RNAC)
is a Sell
Is Cartesian Therapeutics, Inc. overpriced?
-
Cartesian Therapeutics, Inc. has fallen lower in 8 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 88.89%
Cartesian Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cartesiantherapeutics.com
52-Week Data
52-Week High:
18.80
52-Week Low:
5.98
Prediction Charts
Market Cap:
197.6M
Price in USD:
7.60
Volume:
97.9K
Beta:
0.84
Technical Analysis
SMA50:
7.12
SMA100:
7.64
SMA200:
9.23
52-Wk Change:
-59.66%
Stock Predictions
-
Is Cartesian Therapeutics, Inc. stock public?Yes, Cartesian Therapeutics, Inc. is a publicly traded company.
-
What is the Cartesian Therapeutics, Inc. stock quote today?The Cartesian Therapeutics, Inc. stock price is 7.60 USD today.
-
How to buy Cartesian Therapeutics, Inc. stock online?You can buy Cartesian Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-10 | 6.50 | 6.47 | 6.60 | 6.39 |
| Feb-11 | 6.50 | 6.40 | 6.50 | 6.17 |
| Feb-12 | 6.41 | 6.41 | 6.56 | 6.08 |
| Feb-13 | 6.48 | 6.52 | 6.65 | 6.48 |
| Feb-17 | 6.51 | 6.75 | 6.81 | 6.40 |
| Feb-18 | 6.75 | 6.64 | 6.75 | 6.09 |
| Feb-19 | 6.58 | 6.78 | 6.85 | 6.45 |
| Feb-20 | 6.60 | 6.93 | 6.98 | 6.53 |
| Feb-23 | 6.86 | 6.98 | 7.09 | 6.57 |
| Feb-24 | 7.02 | 7.55 | 7.75 | 6.91 |
| Feb-25 | 7.61 | 7.89 | 8.31 | 7.29 |
| Feb-26 | 8.00 | 8.35 | 8.43 | 7.60 |
| Feb-27 | 8.18 | 7.59 | 8.40 | 7.35 |
| Mar-2 | 7.41 | 7.60 | 7.82 | 7.00 |
Cartesian Therapeutics, Inc. Earnings
Cartesian Therapeutics, Inc. Earnings Report: Per Share Cartesian Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cartesian Therapeutics, Inc. Forecast Revenue Growth
Cartesian Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Cartesian Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and an increase next year of $0.22 per share.
* Cartesian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.